Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Histamine H3 Eurofins Panlabs panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting
Assay data:41 Active, 7 Activity ≤ 1 µM, 993 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Assay data:23 Active, 11 Activity ≤ 1 µM, 927 Tested
Displacement of N-alpha-[methyl-3H]-methylhistamine dihydrochloride from Sprague-Dawley rat brain membrane histamine H3 receptor assessed as inhibition constant incubated for 30 mins by liquid scintillation counting analysis
Assay data:21 Active, 21 Activity ≤ 1 µM, 22 Tested
Displacement of N-alpha-[methyl-3H]-methylhistamine dihydrochloride from recombinant human histamine H3 receptor expressed in CHO-K1 cells assessed as inhibition constant incubated for 30 mins by liquid scintillation analysis
Assay data:23 Active, 8 Activity ≤ 1 nM, 23 Activity ≤ 1 µM, 23 Tested
Displacement of N-alpha-[methyl-3H]-methylhistamine dihydrochloride from recombinant human histamine H3 receptor expressed in CHO-K1 cells at 300 nM incubated for 30 mins by liquid scintillation analysis relative to control
SummaryPubMed CitationRelated BioAssays by Target
Displacement of N-alpha-[methyl-3H]-methylhistamine dihydrochloride from Sprague-Dawley rat brain membrane histamine H3 receptor at 300 nM incubated for 30 mins by liquid scintillation counting analysis relative to control
Assay data:2 Tested
Inverse agonist activity at recombinant human histamine H3 receptor expressed in CHO-K1 cells preincubated for 10 mins followed by [35S]GTPgammaS addition and measured after 60 mins by TopCount NXT based scintillation analysis
Assay data:17 Active, 11 Activity ≤ 1 nM, 17 Activity ≤ 1 µM, 17 Tested
Antagonist activity at human histamine H3 receptor expressed in CHO-K1 cells assessed as inhibition of imetit-stimulation ERK1/2 phosphorylation by ELISA analysis
Assay data:17 Active, 17 Activity ≤ 1 µM, 17 Tested
Inverse agonist activity at recombinant human histamine H3 receptor expressed in CHO-K1 cells assessed as maximal efficacy preincubated for 10 mins followed by [35S]GTPgammaS addition and measured after 60 mins by TopCount NXT based scintillation analysis relative to control
Assay data:3 Tested
Antagonist potency at recombinant human histamine H3 receptor expressed in CHO cells assessed as inhibition of histamine stimulated GTPgammaS binding
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Binding affinity to human H3 receptor assessed as inhibition constant incubated for 90 mins by scintillation counting method
Assay data:10 Active, 2 Activity ≤ 1 µM, 15 Tested
Inhibition of human H3 receptor incubated for 90 mins by scintillation counting method relative to control
Inhibition of human H3 receptor at 1 uM incubated for 90 mins by scintillation counting method relative to control
Assay data:6 Tested
Inhibition of human H3 receptor at 10 uM incubated for 90 mins by scintillation counting method relative to control
Assay data:15 Tested
Inhibition of human H3 receptor assessed as inhibition constant incubated for 90 mins by scintillation counting method
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Binding affinity to human H3R expressed in HEK293 cells membrane
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of histamine H3 receptor (unknown origin) at 10 uM
Antagonist activity at H3R (unknown origin)
Assay data:2 Active, 1 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 2 Tested
Determination of Ki Value at Human and Rat Histamin-3 Receptor from US Patent US11622967: "Method of treatment with histamine-3 receptor inverse agonist"
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on